Zoledronic acid in metastatic osteosarcoma: encouraging progression free survival in four consecutive patients

BACKGROUND: Zoledronic acid (ZA) is a third-generation bisphosphonate in widespread clinical use to reduce pain and skeletal events in patients from a variety of malignancies with bone metastases. Pre-clinical studies indicate that ZA inhibits osteosarcoma through direct anti-proliferative effects,...

Descripción completa

Detalles Bibliográficos
Autores principales: Conry, Robert M., Rodriguez, Michael G., Pressey, Joseph G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848872/
https://www.ncbi.nlm.nih.gov/pubmed/27127605
http://dx.doi.org/10.1186/s13569-016-0046-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848872/
https://www.ncbi.nlm.nih.gov/pubmed/27127605
http://dx.doi.org/10.1186/s13569-016-0046-2

Ejemplares similares